Mostrar el registro sencillo del ítem

dc.contributor.advisorAroca Martinez, Gustavo
dc.contributor.advisorMusso, Carlos G.
dc.contributor.authorAvendaño Echávez, Lil Geraldine
dc.date.accessioned2022-01-31T14:14:36Z
dc.date.available2022-01-31T14:14:36Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.12442/9329
dc.description.abstractEl COVID-19 puede afectar muchos otros órganos además del sistema respiratorio, particularmente en el riñón, el corazón, el tracto digestivo, la sangre y el sistema nervioso. En cuanto a las alteraciones renales, los informes preliminares indicaron una incidencia del 3% al 9% y cada vez hay más pruebas de que la lesión renal aguda (IRA) es frecuente en la infección por SARS-CoV-2, con una incidencia informada de 8-17%, llegando al 35% en pacientes críticos, y que esta condición se considera un factor de mal pronóstico. En este sentido, el desarrollo de IRA en el contexto de la COVID-19 tiene una mortalidad asociada del 91,7%.spa
dc.description.abstractCOVID-19 can affect many other organs in addition to the respiratory system, particularly in the kidney, heart , digestive tract, blood, and nervous system. As for the kidney altera t ions , preliminary reports indicated an incidence of 3%–9% and there is growing evidenc e that acute kidney injury (AKI) is prevalent in SARSCoV-2 infection, with a repor t ed incidenc e of 8%–17%, reaching 35% in critical patients , and that this condition is considered a poor prognostic factor. In this sense, the development of AKI in the context of COVID-19 has an associated mortality of 91.7%.spa
dc.format.mimetypepdfspa
dc.language.isospaspa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.publisherFacultad de Ciencias de la Salud
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCOVID 19spa
dc.subjectLesión renal agudaspa
dc.subjectFragilidadspa
dc.subjectCOVID-19eng
dc.subjectAcute kidney injuryeng
dc.subjectFrailtyeng
dc.titleImpacto de la fragilidad y la carga viral en la lesión renal aguda en los pacientes afectados por Covid-19spa
dcterms.referencesWorld Heal th Organization. New Coronavirus . China; 2020eng
dcterms.referencesGorbalenya AE, Baker SC, Baric RS, et al. The species and its viruses—a stateme n t of the Coronavi rus Study Group. Biorxiv . 2020:1-15eng
dcterms.referencesWang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavi rus- infected pneumoni a in Wuhan, China. JAMA . 2020;323(11):1061- 1069eng
dcterms.referencesNaicke r S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel coronavirus 2019 epidemic and kidneys. Kidney Int . 2020;97(5):824- 828. doi: 10.1016/j.kint.2020.03.001 .eng
dcterms.referencesSu H, Yang M, Wan C, et al. Renal histopa thological analysis of 26 postmortem findings of patient s with COVID-19 in China. Kidney Int . 2020;98(1):219- 227. doi: 10.1016/j.kint.2020.04.003 .eng
dcterms.referencesGaba r r e P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patient s with COVID-19. Intensiv e Care Med . 2020;46(7):1339- 1348. doi: 10.1007/ s0013 4- 020- 06153- 9 .eng
dcterms.referencesCheng Y, Luo R, Wang K, et al. Kidney Impai rme nt is associated with in-hospital death of COVID-19 patient s . medRxiv . 2020:1- 21. doi: 10.1101/2020.02.18.20023 2 4 2 .eng
dcterms.referencesSang L, Chen S, Zheng X, et al. The incidenc e, risk factors and prognosis of acut e kidney injury in sever e and critically ill patients with COVID-19 in Mainland China: a ret rospe c t ive study. Research Square; 2020.eng
dcterms.referencesShafi ST. Covid- 19 and acute kidney injury: recent updates . Pak J Kidney Dis . 2020;4(2):225- 227.eng
dcterms.referencesCorman V , Landt O, Kaiser M , Molenkamp R , Meijer A, Chu D , Bleicker T, Brünink S, Schneide r J, Schmidt ML, Mulders D, Haagma ns B, van der Veer B , van den Brink S, Wijsman L, Goder ski G, Romet t e JL , Ellis J , Zambon M , Peiris M, Goossens H, Reusken C , Koopmans M, Drosten C. Detection of 2019 novel coronavi rus (2019- nCoV) by real- time RT-PCR. EURO Surveill. 2020;25(3):23- 30 doi: 10.2807/1560- 7917.ES.2020.25.3.2000 04 5 .eng
dcterms.referencesKDIGO Clinical practic e guideline for acut e kidney injury. Kidney Int Suppl . 2012;2(1):1- 38.eng
dcterms.referencesMusso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disea se: a review of the litera tur e . Int Urol Nephrol . 2015;47(11):1801- 1807.eng
dcterms.referencesKing-Vela E, Muñoz J, Rico- Font alvo J, et al. Acute kidney injury in Colombian patient s with COVID-19 who received kidney support therapy with genius® 90 technology. J Clin Nephrol . 2020;4(3):056- 060.eng
dcterms.referencesGondo- an K, Temel S, Baran Ketencio- lu B, Rabah B, Tutar N, Sungur M. Acute kidney injury in SARS-CoV-2 infected critically ill Patient sTurki sh. J Nephrol . 2020;29:185- 189.eng
dcterms.referencesChan L, Chaudha ry K, Saha A, et al. on behalf of the Mount Sinai COVID Informa t ics Cente r (MSCIC). AKI in hospitalized patient s with COVID-19. JASN Septemb e r 2020. doi: 10.1681/ASN.202005 0 6 1 5eng
dcterms.referencesCheng Y, Luo R, Wang K, et al. Kidney diseas e is associat ed with in-hospital death of patient s with COVID-19. Kidney Int . 2020;97(5):829- 838eng
dcterms.referencesMeijer s B, Hilbrands LB. The clinical characteristics of coronavi rus- associat ed nephropa t hy. Nephrol Dial Transplant . 2020;35(8):1279- 1281. 18. Shafi ST. Covid- 19 and acute kidney injury: recent updates . PJKD. 2020;4(2):225- 227eng
dcterms.referencesMolina- Barraga n AM, Pardo E, Galichon P, et al. SARS-COV2 renal impairment in critical care: A ret rospe c t ive study of 42 cases—Kid COVID Stud y . Resea r ch Squa r e . doi: 10.21203/ r s .3. r s- 64088/v1eng
dcterms.referencesGolmai P, Larsen, DeVita M, et al. Histopa thologic and ultrastructural findings in postmor t em kidney biopsy material in 12 patient s with AKI and COVID-19. JASN . 2020;31:1944- 1947. doi: 10.1681/ASN.202005 0 6 8 3eng
dcterms.referencesBatlle D, Soler MJ, Sparks MA, et al. and on behalf of the COVID. 19 and ACE2 in cardiovascul a r , lung, and Kidney Working Group. Acute kidney injury in COVID19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol . 2020;31(7):1380- 1383. doi: 10.1681/ASN.202004 0 4 1 9 .eng
dcterms.referencesSise ME, Bagge t t MV, Shepa rd JO, Stevens JS, Rhee EP. Case 17- 2020: A 68- year- old man with Covid- 19 and kidney acute injury. N Engl J Med . 2020;382(22):2147- 2156.eng
dcterms.referencesSu H, Yang M, Wan C, et al. Renal histopa thological analysis of 26 postmortem findings of patient s with COVID-19 in China. Kidney Int . 2020;98(1):219- 227. doi: 10.1016/j.kint.2020.04.003 .eng
dcterms.referencesNaicke r S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel coronavi rus 2019 epidemic and kidneys. Kidney Int . 2020;97(5):824- 828eng
dcterms.referencesHernand e z- Arroyo CF, Varghe s e V, Mohamed MMB, Velez JCQ. Urinary sediment microscopy in acute kidney injury associated with COVID-19. Kidney360 . 2020;1(8):819- 823. doi: 10.34067/KID.000335 20 2 0eng
dcterms.referencesPujada s E, Chaudhry F, McBride R, et al. SARS-CoV-2 viral load predict s COVID-19 mor tality. Lancet . 2020;8(9):e70.eng
dcterms.referencesKhan S, Chen L , Yang CR, et al. Does SARS-CoV-2 Infect the Kidney? JASN.2020;31: 1-3 doi: https://doi.org/10.1681/ASN.2020081229eng
dcterms.referencesBraun F, Hube r T, Puelles V. Proximal tubula r dysfunction in patient s with COVID-19: what have we learnt so far? Kidney Int . 2020 Nov; 98(5): 1092–1094. doi: 10.1016/j.kint.2020.09.002eng
dcterms.referencesGonzález C, Yama E, Yomayus a N, et al. [Colombian Consens us of Exper t s on Evidenc e- Informed Recomme n d a t ions for the Prevent ion, Diagnosis and Manageme n t of SARS-CoV-2 / COVID-19 Acute Kidney Injury]. Rev. Colomb. Nefrol. [Interne t ] . 2 de junio de 2020 [citado 1 de noviembr e de 2020];7(Supl.2). https:// revis t an ef rologia.org/index.php/ r cn/ a r t icle/view/473eng
dcterms.referencesLee J, Silberzweig J, Akchurin O, et al. Characteristics of Acute Kidney Injury in Hospitalized COVID-19 Patients in an Urban Academic Medical Center. CJASN. 2021;16:1-3 doi: https://doi.org/10.2215/CJN.07440520eng
dcterms.referencesJingyuan Liu, Yao Liu, Pan Xiang et al. Neut rophil- to-Lymphocyte Ratio Predicts Sever e Illness Patient s with 2019 Novel Coronavirus in the Early Stage. https://doi.org/10.1101/2020.02.10.2002 1 5 8 4eng
dcterms.referencesFei Zhou, Ting Yu, Ronghui Du et al. Clinical cour se and risk factors for mort ality of adult inpatients with COVID-19 in Wuhan, China: a ret rospective cohort Study. Lancet 2020; 395: 1054- 62eng
dcterms.referencesQiurong Ruan , Kun Yang, Wenxia Wang et al. Clinical predictor s of mortality due to COVID-19 based on an analysis of data of 150 patient s from Wuhan, China. Intensive Care Med 2020. Intensive Care Med (2020) 46:846–848 https://doi.org/10.1007/ s001 34- 020- 05991- xeng
dcterms.referencesPáramo Fernánd e z J. Coagula ción, Dímero D y COVID-19. Sociedad Español a de Trombosis y Hemos t a si a (SETH) https://www. s e t h. e s /index.php/noticia s/not icias /not icias- de- la- seth/1588- coagula cion- dimero- d-y-covid- 19.htmlspa
dcterms.referencesPérez G. Coronavi rus . Impacto cardiovascular . Sociedad Interamericana de Cardiología. http://www. sia c a rdio.com/noved ad e s / covid- 19/coronavi rus- ysuimpacto- cardiovascul a r /spa
dcterms.referencesDriggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi- Zoccai G,Brown TS, Nigoghos si an CD, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA, Cardiovascul a r Conside r a t ions for Patient s , Health Care Worker s , and Heal th Systems During the Coronavi rus Disease 2019 (COVID-19) Pandemi c, Journal of the American College of Cardiology (2020), doi:https://doi.org/10.1016/j.jacc.2020.03.031.eng
dcterms.referencesQin C, Zhou L, Hu Z et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clint Infect Dis 2020. https://doi.org/10.1093/ cid/ciaaeng
dcterms.referencesMeht a P, McAuley DF, Brown M, Sanchez E, Tatte r s all RS, Manson JJ. COVID-19: conside r cytokine storm syndrome s and immunosupp r e s s ion. Lancet 2020. https://doi.org/10.1016/S0140- 6736(20)30628- 0eng
sb.sedeSede Barranquillaspa
sb.programaEspecialización en Nefrologíaspa
dc.rights.accessrightsinfo:eu-repo/semantics/restrictedAccessspa
datacite.rightshttp://purl.org/coar/access_right/c_16ecspa
oaire.versioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.spaTrabajo de grado másterspa


Ficheros en el ítem

Thumbnail
Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional